Clinical Trial Update: De-escalation Adjuvant Chemo in HER2+/ER-/node-neg Early BC Patients Who Achieved PCR After Neoadjuvant Chemo & Dual HER2 Blockade [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating de-escalation of adjuvant chemotherapy in patients with HER2-positive, ER-negative, node-negative early breast cancer who achieved a …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Node-negative Breast Cancer

Snippet

Sponsor: Jules Bordet Institute | Conditions: HER2-positive Breast Cancer, ER-Negative Breast Cancer | Phase 2 | Status: TERMINATED